Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012:103:437-49.
doi: 10.1016/B978-0-444-51892-7.00027-9.

Machado-Joseph disease/spinocerebellar ataxia type 3

Affiliations
Review

Machado-Joseph disease/spinocerebellar ataxia type 3

Henry Paulson. Handb Clin Neurol. 2012.

Abstract

Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), may be the most common dominantly inherited ataxia in the world. Here I will review historical, clinical, neuropathological, genetic, and pathogenic features of MJD, and finish with a brief discussion of present, and possible future, treatment for this currently incurable disorder. Like many other dominantly inherited ataxias, MJD/SCA3 shows remarkable clinical heterogeneity, reflecting the underlying genetic defect: an unstable CAG trinucleotide repeat that varies in size among affected persons. This pathogenic repeat in MJD/SCA3 encodes an expanded tract of the amino acid glutamine in the disease protein, which is known as ataxin-3. MJD/SCA3 is one of nine identified polyglutamine neurodegenerative diseases which share features of pathogenesis centered on protein misfolding and accumulation. The specific properties of MJD/SCA3 and its disease protein are discussed in light of what is known about the entire class of polyglutamine diseases.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Ataxin-3 and related Josephin domain proteins
Ataxin-3 is a relatively small protein with a glutamine repeat near the carboxyl terminus. The approximate ranges for normal and disease repeats are shown. The N-terminal conserved “josephin” catalytic domain, a predicted coiled-coil domain and several ubiquitin interacting motifs (UIMs) are also shown. Ataxin-3 is one member of the small Josephin DUB family, two other members of which are josephin-1 and josephin-2, encoded by different genes. All three proteins share the catalytic amino acid triad (C, H, and D/N) and function as DUBs.

Similar articles

Cited by

References

    1. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntington and the risk of neuronal death. Nature. 2004;431:805–810. - PubMed
    1. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 2001;292:1552–5. - PubMed
    1. Berke SJ, Chai Y, Marrs GL, Wen H, Paulson HL. Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3. J Biol Chem. 2005;280(36):32026–34. Epub 2005 Jul 21. - PubMed
    1. Berke SJ, Schmied FA, Brunt ER, Ellerby LM, Paulson HL. Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3. J. Neurochem. 2004 May;89(4):908–18. - PubMed
    1. Bevivino AE, Loll PJ. An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel beta -fibrils. Proc Natl Acad Sci U S A. 2001;98:11955–60. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources